LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka.

RESEARCH PUBLICATIONS

Yahathugoda TC, De Silva NL, Ruben J, Gunawardena S, Weerasooriya MV, Horton J, Budge P, Ottesen E, Sullivan SM, Stephens M, Shen J, Klarmann-Schulz U, Hoerauf A, Shott JP, Mackenzie C.

American Journal of Tropical Medicine and Hygiene. 2024: 111(Suppl 4), 2024, pp. 52–65. PMID: 39043165. PMCID: PMC11448493.

Publication year: 2024

External Link

Professor Sharmini Gunawardena

LEDoxy-SL: A Placebo-Controlled, Double-Blind, Randomized, 24-Month Trial of Six Weeks of Daily Doxycycline Plus Hygiene-Based Essential Care for Reducing Progression of Filarial Lymphedema in Sri Lanka.